Results 1 to 10 of about 10,516 (266)

Cabergoline Treatment in Invasive Giant Prolactinoma

Clinical Medicine Insights: Case Reports, 2014
Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive
Sadeem Alsubaie, Mussa H. Almalki
doaj   +2 more sources

Prolactinoma presenting as chronic anaemia with osteoporosis: a case report

Journal of Medical Case Reports, 2010
Introduction Unexplained anaemia is a rare mode of presentation for prolactinoma. We describe a case of a man, with chronic anaemia ascribed to old age.
Hanley John P, MacLean Fergus R
doaj   +2 more sources

Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis

Open Chemistry, 2019
Resistance to Dopamine agonists therapy is still a key factor that hinders the clinical treatment of prolactinoma. Consequently, a large number of investigations have been carried out to identify novel therapeutic targets.
Lan Xiaolei, Liu Qian, Gao Hua, Li Zhenye, Zhang Yazhuo   +4 more
doaj   +2 more sources

Late presentation of acromegaly in medically controlled prolactinoma patients

Endocrinology, Diabetes & Metabolism Case Reports, 2016
Co-secretion of growth hormone (GH) and prolactin (PRL) from a single pituitary adenoma is common. In fact, up to 25% of patients with acromegaly may have PRL co-secretion.
Ekaterina Manuylova, Laura M Calvi, Catherine Hastings, G Edward Vates, Mahlon D Johnson, William T Cave Jr, Ismat Shafiq   +6 more
doaj   +2 more sources

A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas

Indian Journal of Endocrinology and Metabolism, 2021
Cabergoline has long been used in the medical management of prolactin-secreting pituitary adenomas. However, there is contradicting and inadequate evidence on the efficacy of cabergoline in achieving radiological and biochemical remission in prolactinoma.
Rakesh Mishra, Subhas K Konar, Adesh Shrivastava, Pradeep Chouksey, Sumit Raj, Amit Agrawal   +5 more
doaj   +1 more source

Co-Morbidity of Pituitary Adenoma and Frontal Convexity Meningioma: A Case Report and Review of the Literature

International Clinical Neuroscience Journal, 2020
Instruction: The current study reports a woman with pituitary adenoma and frontal convexity meningioma that was detected accidentally. To the best of our knowledge, this case is considered as a rare clinical scenario.
Thi Phuong Hoai Dinh, Dang Thi Mai, Van Tri Truong   +2 more
doaj   +1 more source

Increased expression of aromatase cytochrome P450 enzyme is associated with prolactinoma invasiveness in post-menopausal women

Journal of International Medical Research, 2019
Objectives To investigate the expression levels of aromatase cytochrome P450 enzyme (P450AROM) and related molecules—estrogen receptor-beta (ER-β), Ki-67, and p53—in prolactinoma tumor tissue from pre- and post-menopausal women, and to determine the ...
Yin-Xia Su, Guo-Li Du, Hong-Li Shen, Wen Wang, Jian-Ling Bao, Aizezijiang Aierken, Bo-Wei Wang, Sheng Jiang, Jun Zhu, Xiao-Ming Gao   +9 more
doaj   +1 more source

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas

Frontiers in Endocrinology, 2022
BackgroundProlactinoma is the most common type of pituitary tumors, and its resultant tumor occupying and hormone disturbance greatly damage the health of patients.
Kejing Zhu, Kejing Zhu, Kejing Zhu, Kejing Zhu, Xueting Cheng, Shuman Wang, Hong Zhang, Yu Zhang, Xiong Wang, Yonggang Chen, Jinhu Wu   +10 more
doaj   +1 more source

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy

Indian Journal of Endocrinology and Metabolism, 2011
Management of prolactinoma in pregnancy is a big challenge for the treating obstetrician as prolactin levels are normally raised in pregnancy and this creates a possibility of missing the diagnosis of prolactinoma.
Sukhwinder Kaur Bajwa, Sukhminder Jit Singh Bajwa, Praveen Mohan, Anita Singh   +3 more
doaj   +1 more source

Menstrual cycle abnormalities in patients with prolactinoma and drug-induced hyperprolactinemia

Indian Journal of Endocrinology and Metabolism, 2017
Background and Objective: Hyperprolactinemia affects the reproductive endocrine axis; however, the degree of dysfunction may vary depending on etiology.
Bindu Kulshreshtha, Isha Pahuja, Deepak Kothari, Indu Chawla, Neera Sharma, Shikha Gupta, Anuja Mittal   +6 more
doaj   +1 more source